The low number and low expression of HER2 on the EVs of healthy donors, in comparison to the high number and expression of HER2 on the EVs of patients with HER2high tumours, was used to calculate a logistic regression for classification of these two groups. This evidence concerns the gene ERBB2 and neoplasm.